FRIBERG GREGORY R (EVP, Chief R&D Officer) sold 14.4% of their position (6.33K shares) of BIOMARIN PHARMACEUTICAL INC on the open market
Open‑market sale worth $381.9K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/26/2026ACC: 0001628280-26-012539
Officer· EVP, Chief R&D Officer
Since Feb 2026
-6.33K
Net shares
Net seller
$381.9K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
6.33K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−6.33K
Price / share
$60.38
Trade value
$381.94K
% of position
14.4%
2/26/2026
43.90K→37.58K
Total
Net shares
−6.33K
Net value
-$381.94K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/26/2026 | S · Sale | −6.33K | $60.38 | $381.94K | 14.4% | 43.90K | 37.58K |
| Total | −6.33K | -$381.94K | ||||||
Derivative Transactions0
No derivative transactions reported